A GenMark Diagnostics Inc. investor sued it in Delaware, seeking internal files to investigate allegations that its board succumbed to conflicts of interest in backing its $1.8 billion sale to
The board’s close engagement with Roche during pre-deal talks and its “apparent indifference” to a rival suitor showing “strong interest” create “a credible basis to suspect” that “potential favoritism” led the directors to “short-circuit” the sales process to secure perks for themselves, the complaint says.
The lawsuit, filed late Wednesday in Delaware Chancery Court, cites “financial incentives” ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.